SEC Form 4/A · accession 0001104659-19-012549
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John M Siebert
Director
Period of report
Feb 22, 2019
Accepted (ET)
Mar 4, 2019 · 5:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 35,742 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) | $36.75 | Feb 22, 2019 | A | 12,427 | A | Feb 22, 2020 | Feb 22, 2029 | Common Stock | 12,427 | 12,427 | D |
Explanation of responses
- F1The Reporting Person is amending the Form 4 filed on February 26, 2019 to reflect the fact that the number of securities owned should be 35,742 shares rather than the 19,563 shares originally reported. There are no other amendments to the original report.